Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women
Not Applicable
Terminated
- Conditions
- Healthy Women VolunteersHIV Infected Women
- Interventions
- Procedure: vaginal swabs by washing and cytobrush
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 14
- Registration Number
- NCT01715103
- Locations
- 🇫🇷
Centre d'investigation clinique Cochin Pasteur (CIC1417), Paris, France
🇫🇷Service des maladies infectieuses et tropicales, Saint Etienne, France
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
Phase 2
Completed
- Conditions
- HIV-2 Infection
- Interventions
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 30
- Registration Number
- NCT01605890
- Locations
- 🇫🇷
Hôpital Bichat-Claude Bernard, Paris, France
Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2014-02-07
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 138
- Registration Number
- NCT01545544
- Locations
- 🇫🇷
Hôpital Necker, Paris, France
the ANRS CO21 " Extreme " Cohort (CODEX)
Not Applicable
- Conditions
- HIV Infection
- Interventions
- Biological: blood sampling
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 300
- Registration Number
- NCT01520844
- Locations
- 🇫🇷
Lambotte, Kremlin Bicetre, France
French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 675
- Registration Number
- NCT01514890
- Locations
- 🇫🇷
Hôpital Henri Mondor, Créteil, France
Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence
Not Applicable
Completed
- Conditions
- HIV Infection
- Interventions
- Drug: Immediate ARV treatment initiation with TDF/FTC/EFVOther: South African recommendation guided ARV (TDF/FTC/EFV) initiation
- First Posted Date
- 2012-01-13
- Last Posted Date
- 2016-07-21
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 28153
- Registration Number
- NCT01509508
- Locations
- 🇿🇦
Hlabisa Hospital, Hlabisa, KwaZulu-Natal, South Africa
Lipopeptide Immunisation With GTU-multiHIV Trial
Phase 2
Completed
- Conditions
- HIV-1 Infection
- Interventions
- Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccinesBiological: GTU-multHIV B vaccine and LIPO-5 vaccine
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 103
- Registration Number
- NCT01492985
- Locations
- 🇫🇷
Service d'Immunologie clinique, Centre de vaccination anti-VIH ANRS Mondor Ile-de-France, Hôpital Henri Mondor, Créteil, France
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
- First Posted Date
- 2011-11-17
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 400
- Registration Number
- NCT01473472
- Locations
- 🇫🇷
CHU Hôtel Dieu, Nantes, France
🇫🇷Hôpital de l'Archet, Nice, France
🇫🇷Hôpital Gustave Dron, Tourcoing, France
Renal Transplantation and Raltegravir in HIV-Infected Patients
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 27
- Registration Number
- NCT01453192
- Locations
- 🇫🇷
Hôpital Kremlin Bicêtre, Service de Néphrologie, Kremlin Bicêtre, France
🇫🇷Hôpital Henri Mondor, Service de Néphrologie Transplantation, Créteil, France
🇫🇷CHRU Lille, Service de néphrologie, Lille, France
Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
Phase 2
Terminated
- Conditions
- LipohypertrophyHuman Immunodeficiency Virus
- Interventions
- Drug: Raltegravir-Maraviroc
- First Posted Date
- 2011-08-19
- Last Posted Date
- 2015-07-24
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 48
- Registration Number
- NCT01420523
- Locations
- 🇫🇷
Hôpital Pitié Salpétrière, Paris, France
© Copyright 2025. All Rights Reserved by MedPath